Gender-specific effect of smoking on upper tract urothelial carcinoma outcomes
Standard
Gender-specific effect of smoking on upper tract urothelial carcinoma outcomes. / Rink, Michael; Xylinas, Evanguelos; Trinh, Quoc-Dien; Lotan, Yair; Margulis, Vitaly; Raman, Jay D; Fisch, Margit; Lee, Richard K; Chun, Felix K; Abdennabi, Joual; Seitz, Christian; Pycha, Armin; Zlotta, Alexandre R; Karakiewicz, Pierre I; Babjuk, Marko; Scherr, Douglas S; Shariat, Shahrokh F; Upper Tract Urothelial Carcinoma Collaboration (UTUCC).
in: BJU INT, Jahrgang 112, Nr. 5, 01.09.2013, S. 623-37.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Gender-specific effect of smoking on upper tract urothelial carcinoma outcomes
AU - Rink, Michael
AU - Xylinas, Evanguelos
AU - Trinh, Quoc-Dien
AU - Lotan, Yair
AU - Margulis, Vitaly
AU - Raman, Jay D
AU - Fisch, Margit
AU - Lee, Richard K
AU - Chun, Felix K
AU - Abdennabi, Joual
AU - Seitz, Christian
AU - Pycha, Armin
AU - Zlotta, Alexandre R
AU - Karakiewicz, Pierre I
AU - Babjuk, Marko
AU - Scherr, Douglas S
AU - Shariat, Shahrokh F
AU - Upper Tract Urothelial Carcinoma Collaboration (UTUCC)
N1 - © 2013 BJU International.
PY - 2013/9/1
Y1 - 2013/9/1
N2 - OBJECTIVE: To evaluate the gender-specific differential effects of smoking habits and cumulative smoking exposure on outcomes in patients with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy (RNU).PATIENTS AND METHODS: A total of 864 consecutive patients, comprising 553 (64%) men and 311 (36%) women, from five international institutions underwent RNU without neoadjuvant chemotherapy. Smoking history included smoking status (current, former or never), quantity of cigarettes per day (CPD), smoking duration in years and years since smoking cessation. Cumulative smoking exposure was categorized as light short-term (≤19 CPD and ≤19.9 years), moderate (all combinations except light short-term and heavy long-term), and heavy long-term (≥20 CPD and ≥20 years). Uni- and multivariable competing risk regression models were used to assess the associations with outcomes.RESULTS: Overall, 244 (28.2%), 297 (34.4%) and 323 (37.4%) patients were never, former and current smokers, respectively. There were no differences in smoking status, quantity and duration between the genders. In female ever smokers, 30 (9.6%), 121 (38.9%) and 67 (21.5%) were light short-term, moderate and heavy long-term smokers, respectively. Compared with men, female current smokers were more likely to experience disease recurrence in univariable analysis (P = 0.013). In heavy long-term smokers, female gender was significantly associated with disease recurrence (hazard ratio [HR] 1.7; P = 0.03) and cancer-specific mortality (HR 2.0; P = 0.009) in multivariable analysis that adjusted for standard clinico-pathological features. In female patients only, smoking quantity, duration and cumulative exposure were associated with disease recurrence and cancer-specific mortality on multivariable analyses (P ≤ 0.025).CONCLUSIONS: The impact of smoking on UTUC outcomes after RNU is gender-specific. Females who are current and heavy long-term smokers experience worse outcomes than their male counterparts. Further research is needed to elucidate the molecular mechanisms underlying the gender-specific differential effect of smoking on UTUC outcomes.
AB - OBJECTIVE: To evaluate the gender-specific differential effects of smoking habits and cumulative smoking exposure on outcomes in patients with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy (RNU).PATIENTS AND METHODS: A total of 864 consecutive patients, comprising 553 (64%) men and 311 (36%) women, from five international institutions underwent RNU without neoadjuvant chemotherapy. Smoking history included smoking status (current, former or never), quantity of cigarettes per day (CPD), smoking duration in years and years since smoking cessation. Cumulative smoking exposure was categorized as light short-term (≤19 CPD and ≤19.9 years), moderate (all combinations except light short-term and heavy long-term), and heavy long-term (≥20 CPD and ≥20 years). Uni- and multivariable competing risk regression models were used to assess the associations with outcomes.RESULTS: Overall, 244 (28.2%), 297 (34.4%) and 323 (37.4%) patients were never, former and current smokers, respectively. There were no differences in smoking status, quantity and duration between the genders. In female ever smokers, 30 (9.6%), 121 (38.9%) and 67 (21.5%) were light short-term, moderate and heavy long-term smokers, respectively. Compared with men, female current smokers were more likely to experience disease recurrence in univariable analysis (P = 0.013). In heavy long-term smokers, female gender was significantly associated with disease recurrence (hazard ratio [HR] 1.7; P = 0.03) and cancer-specific mortality (HR 2.0; P = 0.009) in multivariable analysis that adjusted for standard clinico-pathological features. In female patients only, smoking quantity, duration and cumulative exposure were associated with disease recurrence and cancer-specific mortality on multivariable analyses (P ≤ 0.025).CONCLUSIONS: The impact of smoking on UTUC outcomes after RNU is gender-specific. Females who are current and heavy long-term smokers experience worse outcomes than their male counterparts. Further research is needed to elucidate the molecular mechanisms underlying the gender-specific differential effect of smoking on UTUC outcomes.
KW - Aged
KW - Aged, 80 and over
KW - Carcinoma, Transitional Cell
KW - Female
KW - Follow-Up Studies
KW - Humans
KW - Kaplan-Meier Estimate
KW - Male
KW - Middle Aged
KW - Neoplasm Recurrence, Local
KW - Nephrectomy
KW - Prognosis
KW - Retrospective Studies
KW - Risk Assessment
KW - Sex Distribution
KW - Sex Factors
KW - Smoking
KW - Smoking Cessation
KW - Time Factors
KW - Ureteral Neoplasms
KW - Urothelium
U2 - 10.1111/bju.12014
DO - 10.1111/bju.12014
M3 - SCORING: Journal article
C2 - 23465088
VL - 112
SP - 623
EP - 637
JO - BJU INT
JF - BJU INT
SN - 1464-4096
IS - 5
ER -